Immunization of MS patients with irradiated autologous encephalitogenic myelin peptides (EMP) specific T-cell lines or clones.
Clinical immunologic and neuroradiologic evaluation.
Age
16–60
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Definite MS (post criteria)
Relapsing remitting or primary progressive clinical course. At least one relapse in the last two years.
Disease duration \> 1 year
Expanded Disability Status Scale (EDSS) between 0-6
Brain magnetic resonance imaging (MRI) compatible with MS
Not involved in any other clinical trials
No other systemic disease
You may not be if
Does not comply with the above
Clareo Health | T-Cell Vaccination in Multiple Sclerosis (MS)
